1. Home
  2. EQBK vs EMBC Comparison

EQBK vs EMBC Comparison

Compare EQBK & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EQBK
  • EMBC
  • Stock Information
  • Founded
  • EQBK 2002
  • EMBC 1924
  • Country
  • EQBK United States
  • EMBC United States
  • Employees
  • EQBK N/A
  • EMBC N/A
  • Industry
  • EQBK Major Banks
  • EMBC Medical/Dental Instruments
  • Sector
  • EQBK Finance
  • EMBC Health Care
  • Exchange
  • EQBK Nasdaq
  • EMBC Nasdaq
  • Market Cap
  • EQBK 696.9M
  • EMBC 726.8M
  • IPO Year
  • EQBK 2015
  • EMBC N/A
  • Fundamental
  • Price
  • EQBK $36.51
  • EMBC $9.96
  • Analyst Decision
  • EQBK Buy
  • EMBC Buy
  • Analyst Count
  • EQBK 6
  • EMBC 2
  • Target Price
  • EQBK $45.60
  • EMBC $19.00
  • AVG Volume (30 Days)
  • EQBK 102.9K
  • EMBC 526.4K
  • Earning Date
  • EQBK 07-14-2025
  • EMBC 08-08-2025
  • Dividend Yield
  • EQBK 1.60%
  • EMBC 5.91%
  • EPS Growth
  • EQBK 541.52
  • EMBC N/A
  • EPS
  • EQBK 4.01
  • EMBC 0.89
  • Revenue
  • EQBK $227,863,000.00
  • EMBC $1,079,500,000.00
  • Revenue This Year
  • EQBK $20.94
  • EMBC N/A
  • Revenue Next Year
  • EQBK $10.08
  • EMBC N/A
  • P/E Ratio
  • EQBK $9.37
  • EMBC $11.39
  • Revenue Growth
  • EQBK 49.19
  • EMBC N/A
  • 52 Week Low
  • EQBK $32.95
  • EMBC $9.20
  • 52 Week High
  • EQBK $50.85
  • EMBC $21.48
  • Technical
  • Relative Strength Index (RSI)
  • EQBK 26.42
  • EMBC 43.81
  • Support Level
  • EQBK $37.85
  • EMBC $9.68
  • Resistance Level
  • EQBK $38.79
  • EMBC $11.79
  • Average True Range (ATR)
  • EQBK 0.91
  • EMBC 0.51
  • MACD
  • EQBK -0.47
  • EMBC -0.05
  • Stochastic Oscillator
  • EQBK 6.83
  • EMBC 22.12

About EQBK Equity Bancshares Inc.

Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: